Inflammation

Belgium recall same curcumin-based supplement linked to Italian hepatitis cases

15-Jul-2019 By Will Chu

Belgium’s Federal Agency for Food Chain Safety (AFSCA) warns consumers to avoid the same curcumin-based supplement known to Italian authorities after the country also reports cases of acute cholestatic hepatitis.

UK CBD group call on industry to prepare ‘strong foundation’ as sector booms

02-Jul-2019 By Will Chu

The Centre for Medicinal Cannabis (CMC) is calling on politicians, policy-makers, regulators, producers and retailers to play their part in contributing to the success of the cannabidiol (CBD) sector in the UK.

Gut-brain axis may be bridge linking chronic pain with microbiome changes

21-Jun-2019 By Will Chu

A Canadian study reveals the gut bacteria’s relationship with chronic pain in findings that identify changes in the gut microbiome in people with fibromyalgia.

Synthetic chili pepper extract gets EFSA approval

20-Jun-2019 By Will Chu

The European Food and Safety Authority (EFSA) finds no safety concerns with the Novel Food (NF) phenylcapsaicin, a synthetic chemical compound of the chili pepper extract capsaicin.

Bulgaria in contention to be first EU country to allow open sale of CBD

11-Jun-2019 By Will Chu

Bulgaria could be the first country in Europe to permit the sale of hemp-derived cannabidiol (CBD) nutraceutical products on the open market, granting authorisation to US-based firm Kannaway.

Italy’s Supreme Court ruling casts legal doubt among country’s ‘cannabis light’ industry

10-Jun-2019 By Will Chu

Italy’s Supreme Court has ruled the sale of all cannabis derivatives such as oils, resins, buds and leaves as illegal in a decision that in principle outlaws sales of ‘cannabis light’ products.

Sabinsa adds three manufacturing sites to USP GMP verification program

22-May-2019 By Hank Schultz

Three additional manufacturing sites in India now have third party GMP verification, according to ingredient supplier Sabinsa.

UPDATE: Hepatitis cases linked to turmeric supplements rumble on as incidences rise to ten

21-May-2019 By Will Chu

Italy’s National Institute of Health reports a further six new hepatitis incidences linked to the consumption of turmeric-based food supplements bringing the total to ten cases.

Hepatitis cases linked to turmeric supplements rises to four, say Italian authorities

17-May-2019 By Will Chu

Italy’s National Institute of Health has received further notifications of two more hepatitis cases linked to a turmeric-based food supplement distributed by a firm already implicated in two similar incidents earlier this month.

Mental Health Awareness Week

Expert view: How diet reversed my depression

16-May-2019 By Nikki Cutler

A plant-based nutritionist revealed at Vitafood last week how changing her diet reversed the depression that caused chronic health issues throughout her childhood.

VITAFOODS 2019

Supplements and beyond: CBD industry on cusp of cannabis revolution - WATCH

15-May-2019 By Will Chu

The European Commission’s decision to classify cannabidiol (CBD)-containing products as a 'novel food,' continues to irk those in the sector as the nutrition industry gather once more for Vitafoods.

Industry group despair at 'disproportionate & senseless measures' put on CBD products

14-May-2019 By Will Chu

The European Industrial Hemp Association (EIHA) has described regulatory measures taken against CBD-containing products as “disproportionate and senseless,” in moves that have bought “negative consequences”.

Arjuna Natural expands stronghold in Europe with curcumin patent approval

11-Apr-2019 By Nikki Cutler

Indian spice and botanical extract manufacturer Arjuna Natural has been granted a new patent in Europe for its applied technology, which improves the bioavailability of curcumin in a 100% natural formulation.

French authorities issue warning for populations to avoid joint health supplements

08-Apr-2019 By Will Chu

Select populations should avoid consuming food supplements containing glucosamine and/or chondroitin sulphate, French authorities warn after receiving a series of reported adverse events.

Chr. Hansen lends its microbiome knowhow in Lonza biotherapeutics deal

05-Apr-2019 By Will Chu

Chr. Hansen applies its microbiome expertise in the pharma arena as the firm enters a collaboration with Lonza to produce live biotherapeutic (LBP) products that address a range of gastrointestinal and cardiovascular conditions.